<p><strong>云米科技有限公司</strong>（NASDAQ:VIOT）的股价在过去一个月表现非常糟糕，下降了 27%。从更大的角度来看，即使在这个糟糕的月份之后，该股票在过去一年中仍上涨了 67%。</p>
<p>即使在如此大幅的价格下跌之后，仍然可以说云米科技目前的市销率（&#34;P/S&#34;）为 0.4 倍，相较于美国消费品耐用品行业的中位数市销率约为 0.6 倍，似乎显得相当&#34;中规中矩&#34;。不过，简单忽视市销率并不明智，因为投资者可能会忽略一个独特的机会或一个代价高昂的错误。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对云米科技的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/579118862-ps-multiple-vs-industry-1-dark-2/1763900982846?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/579118862-ps-multiple-vs-industry-1-dark-2/1763900982846"/></p>
<p>纳斯达克 GS:VIOT 市销率与行业比较 2025 年 11 月 23 日</p>
<h3>云米科技最近的表现如何？</h3>
<p>云米科技的收入增长优于最近大多数其他公司，表现相对良好。一个可能性是，市销率适中是因为投资者认为这种强劲的收入表现可能即将减弱。如果公司能够保持现状，那么投资者应该会获得与其收入数据相匹配的股价回报。</p>
<p>想要了解分析师对公司的完整预测吗？那么我们 <strong>免费的</strong> 云米科技报告将帮助你揭示未来的趋势。</p>
<h2>云米科技的收入增长是否有预测？</h2>
<p>有一个内在的假设，即公司应该与行业的市销率相匹配，像云米科技这样的市销率才被认为是合理的。</p>
<p>首先回顾一下，我们看到公司去年收入增长了令人印象深刻的 24%。然而，这还不够，因为最近三年期间，公司总收入经历了 31% 的大幅下降。因此，股东们对中期收入增长率感到沮丧。</p>
<p>展望未来，唯一覆盖该公司的分析师的估计显示，预计收入在明年将增长 7.5%。这将显著高于更广泛行业的 1.9% 增长预测。</p>
<p>考虑到这一点，我们发现云米科技的市销率与其行业同行密切相关，这一点令人感兴趣。大多数投资者可能并不相信公司能够实现未来的增长预期。</p>
<h2>我们可以从云米科技的市销率中学到什么？</h2>
<p>云米科技股价的暴跌使其市销率回到了与行业其他公司相似的水平。虽然市销率不应该是决定是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
<p>我们已经确定，云米科技目前的市销率低于预期，因为其预测的收入增长高于更广泛的行业。当我们看到强劲的收入前景，且增长超过行业时，我们只能假设这些数字周围的潜在不确定性可能是对市销率施加轻微压力的原因。至少价格下跌的风险似乎被抑制，但投资者似乎认为未来的收入可能会出现一些波动。</p>
<p>在投资之前，还有其他重要的风险因素需要考虑，我们发现 <strong>云米科技有 1 个警示信号</strong>，你应该注意。</p>
<p>如果你对云米科技的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些你可能错过的基本面良好的其他公司呢？</p>

云米

<p>云米科技有限公司（NASDAQ:VIOT）股票近期暴跌 27%，但在过去一年中仍上涨 67%。尽管收入增长强劲，其市销率为 0.4 倍，低于行业中位数的 0.6 倍，这表明投资者对未来增长的不确定性。分析师预测收入将增长 7.5%，高于行业的 1.9%。投资者保持谨慎，考虑到未来收入可能的波动性</p>

<p>The <strong>Viomi Technology Co., Ltd</strong> (NASDAQ:VIOT) share price has fared very poorly over the last month, falling by a substantial 27%. Looking at the bigger picture, even after this poor month the stock is up 67% in the last year.</p>
<div class="lb-trans"><p><strong>云米科技有限公司</strong>（NASDAQ:VIOT）的股价在过去一个月表现非常糟糕，下降了 27%。从更大的角度来看，即使在这个糟糕的月份之后，该股票在过去一年中仍上涨了 67%。</p>
</div><p>Even after such a large drop in price, it's still not a stretch to say that Viomi Technology's price-to-sales (or &#34;P/S&#34;) ratio of 0.4x right now seems quite &#34;middle-of-the-road&#34; compared to the Consumer Durables industry in the United States, where the median P/S ratio is around 0.6x. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.</p>
<div class="lb-trans"><p>即使在如此大幅的价格下跌之后，仍然可以说云米科技目前的市销率（&#34;P/S&#34;）为 0.4 倍，相较于美国消费品耐用品行业的中位数市销率约为 0.6 倍，似乎显得相当&#34;中规中矩&#34;。不过，简单忽视市销率并不明智，因为投资者可能会忽略一个独特的机会或一个代价高昂的错误。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>See our latest analysis for Viomi Technology</p>
<div class="lb-trans"><p>查看我们对云米科技的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/579118862-ps-multiple-vs-industry-1-dark-2/1763900982846" alt="" original-src="https://images.simplywall.st/asset/chart/579118862-ps-multiple-vs-industry-1-dark-2/1763900982846"/></p>
<p>NasdaqGS:VIOT Price to Sales Ratio vs Industry November 23rd 2025</p>
<div class="lb-trans"><p>纳斯达克 GS:VIOT 市销率与行业比较 2025 年 11 月 23 日</p>
</div><h3>How Has Viomi Technology Performed Recently?</h3>
<div class="lb-trans"><h3>云米科技最近的表现如何？</h3>
</div><p>With revenue growth that's superior to most other companies of late, Viomi Technology has been doing relatively well. One possibility is that the P/S ratio is moderate because investors think this strong revenue performance might be about to tail off. If the company manages to stay the course, then investors should be rewarded with a share price that matches its revenue figures.</p>
<div class="lb-trans"><p>云米科技的收入增长优于最近大多数其他公司，表现相对良好。一个可能性是，市销率适中是因为投资者认为这种强劲的收入表现可能即将减弱。如果公司能够保持现状，那么投资者应该会获得与其收入数据相匹配的股价回报。</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on Viomi Technology will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析师对公司的完整预测吗？那么我们 <strong>免费的</strong> 云米科技报告将帮助你揭示未来的趋势。</p>
</div><h2>Is There Some Revenue Growth Forecasted For Viomi Technology?</h2>
<div class="lb-trans"><h2>云米科技的收入增长是否有预测？</h2>
</div><p>There's an inherent assumption that a company should be matching the industry for P/S ratios like Viomi Technology's to be considered reasonable.</p>
<div class="lb-trans"><p>有一个内在的假设，即公司应该与行业的市销率相匹配，像云米科技这样的市销率才被认为是合理的。</p>
</div><p>Taking a look back first, we see that the company grew revenue by an impressive 24% last year. However, this wasn't enough as the latest three year period has seen the company endure a nasty 31% drop in revenue in aggregate. Accordingly, shareholders would have felt downbeat about the medium-term rates of revenue growth.</p>
<div class="lb-trans"><p>首先回顾一下，我们看到公司去年收入增长了令人印象深刻的 24%。然而，这还不够，因为最近三年期间，公司总收入经历了 31% 的大幅下降。因此，股东们对中期收入增长率感到沮丧。</p>
</div><p>Shifting to the future, estimates from the only analyst covering the company suggest revenue should grow by 7.5% over the next year. That's shaping up to be materially higher than the 1.9% growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未来，唯一覆盖该公司的分析师的估计显示，预计收入在明年将增长 7.5%。这将显著高于更广泛行业的 1.9% 增长预测。</p>
</div><p>With this in consideration, we find it intriguing that Viomi Technology's P/S is closely matching its industry peers. It may be that most investors aren't convinced the company can achieve future growth expectations.</p>
<div class="lb-trans"><p>考虑到这一点，我们发现云米科技的市销率与其行业同行密切相关，这一点令人感兴趣。大多数投资者可能并不相信公司能够实现未来的增长预期。</p>
</div><h2>What We Can Learn From Viomi Technology's P/S?</h2>
<div class="lb-trans"><h2>我们可以从云米科技的市销率中学到什么？</h2>
</div><p>Viomi Technology's plummeting stock price has brought its P/S back to a similar region as the rest of the industry. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.</p>
<div class="lb-trans"><p>云米科技股价的暴跌使其市销率回到了与行业其他公司相似的水平。虽然市销率不应该是决定是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
</div><p>We've established that Viomi Technology currently trades on a lower than expected P/S since its forecasted revenue growth is higher than the wider industry. When we see a strong revenue outlook, with growth outpacing the industry, we can only assume potential uncertainty around these figures are what might be placing slight pressure on the P/S ratio. At least the risk of a price drop looks to be subdued, but investors seem to think future revenue could see some volatility.</p>
<div class="lb-trans"><p>我们已经确定，云米科技目前的市销率低于预期，因为其预测的收入增长高于更广泛的行业。当我们看到强劲的收入前景，且增长超过行业时，我们只能假设这些数字周围的潜在不确定性可能是对市销率施加轻微压力的原因。至少价格下跌的风险似乎被抑制，但投资者似乎认为未来的收入可能会出现一些波动。</p>
</div><p>There are also other vital risk factors to consider before investing and we've discovered <strong>1 warning sign for Viomi Technology</strong> that you should be aware of.</p>
<div class="lb-trans"><p>在投资之前，还有其他重要的风险因素需要考虑，我们发现 <strong>云米科技有 1 个警示信号</strong>，你应该注意。</p>
</div><p>If you're <strong>unsure about the strength of Viomi Technology's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果你对云米科技的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些你可能错过的基本面良好的其他公司呢？</p>
</div>

由于云米科技有限公司（NASDAQ:VIOT）的股价暴跌 27%，目前还没有很多投资者涌入该股